Monday, 25 September 2017

Synthace raises a £7.3m Series A to bring open source to biotech

 Synthace, a UK startup using open source technology to make process in biotechnology move faster, has raises a £7.3m Series A round. New investors White Cloud Capital, Amadeus Capital Partners and Eleven Two Capital participated alongside existing investors that included Sofinnova Partners, SOSV and Bioeconomy Capital. The Company’s Antha operating system replaces processes which are… Read More
Disqus Comments